116 related articles for article (PubMed ID: 38663352)
1. Stratification of glioma based on stemness scores in bulk and single-cell transcriptomes.
Abdelrahman Z; Abdelatty A; Luo J; McKnight AJ; Wang X
Comput Biol Med; 2024 Jun; 175():108304. PubMed ID: 38663352
[TBL] [Abstract][Full Text] [Related]
2. Identification of Glioma Cancer Stem Cell Characteristics Based on Weighted Gene Prognosis Module Co-Expression Network Analysis of Transcriptome Data Stemness Indices.
Xia P; Li Q; Wu G; Huang Y
J Mol Neurosci; 2020 Oct; 70(10):1512-1520. PubMed ID: 32451841
[TBL] [Abstract][Full Text] [Related]
3. Classification of lung adenocarcinoma based on stemness scores in bulk and single cell transcriptomes.
Liu Q; Lei J; Zhang X; Wang X
Comput Struct Biotechnol J; 2022; 20():1691-1701. PubMed ID: 35495113
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
5. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
[TBL] [Abstract][Full Text] [Related]
6. The Role Played by SLUG, an Epithelial-Mesenchymal Transition Factor, in Invasion and Therapeutic Resistance of Malignant Glioma.
Oh SJ; Ahn EJ; Kim O; Kim D; Jung TY; Jung S; Lee JH; Kim KK; Kim H; Kim EH; Lee KH; Moon KS
Cell Mol Neurobiol; 2019 Aug; 39(6):769-782. PubMed ID: 31011939
[TBL] [Abstract][Full Text] [Related]
7. PER2 inhibits proliferation and stemness of glioma stem cells via the Wnt/β‑catenin signaling pathway.
Ma D; Hou L; Xia H; Li H; Fan H; Jia X; Niu Z
Oncol Rep; 2020 Aug; 44(2):533-542. PubMed ID: 32468039
[TBL] [Abstract][Full Text] [Related]
8. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.
Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS
Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251
[TBL] [Abstract][Full Text] [Related]
9. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
10. Radioresistant glioma stem cells--therapeutic obstacle or promising target?
Chalmers AJ
DNA Repair (Amst); 2007 Sep; 6(9):1391-4. PubMed ID: 17482890
[TBL] [Abstract][Full Text] [Related]
11. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
Bao S; Wu Q; McLendon RE; Hao Y; Shi Q; Hjelmeland AB; Dewhirst MW; Bigner DD; Rich JN
Nature; 2006 Dec; 444(7120):756-60. PubMed ID: 17051156
[TBL] [Abstract][Full Text] [Related]
12. NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
Hu PS; Xia QS; Wu F; Li DK; Qi YJ; Hu Y; Wei ZZ; Li SS; Tian NY; Wei QF; Shen LJ; Yin B; Jiang T; Yuan JG; Qiang BQ; Han W; Peng XZ
Oncogene; 2017 Aug; 36(33):4706-4718. PubMed ID: 28394339
[TBL] [Abstract][Full Text] [Related]
13. Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma.
Sharma M; Barravecchia I; Magnuson B; Ferris SF; Apfelbaum A; Mbah NE; Cruz J; Krishnamoorthy V; Teis R; Kauss M; Koschmann C; Lyssiotis CA; Ljungman M; Galban S
Neoplasia; 2023 Oct; 44():100931. PubMed ID: 37647805
[TBL] [Abstract][Full Text] [Related]
14. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers in glioma.
Ludwig K; Kornblum HI
J Neurooncol; 2017 Sep; 134(3):505-512. PubMed ID: 28233083
[TBL] [Abstract][Full Text] [Related]
16.
Gao X; Liu Y; Hong S; Yang H; Guan B; Ma X
J Integr Neurosci; 2023 Aug; 22(5):135. PubMed ID: 37735118
[TBL] [Abstract][Full Text] [Related]
17. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
Ius T; Ciani Y; Ruaro ME; Isola M; Sorrentino M; Bulfoni M; Candotti V; Correcig C; Bourkoula E; Manini I; Pegolo E; Mangoni D; Marzinotto S; Radovic S; Toffoletto B; Caponnetto F; Zanello A; Mariuzzi L; Di Loreto C; Beltrami AP; Piazza S; Skrap M; Cesselli D
Neuro Oncol; 2018 May; 20(6):776-787. PubMed ID: 29228370
[TBL] [Abstract][Full Text] [Related]
18. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
Ma XL; Shang F; Ni W; Zhu J; Luo B; Zhang YQ
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2351-2366. PubMed ID: 30225541
[TBL] [Abstract][Full Text] [Related]
20. The Glioma Stem Cell Model in the Era of Single-Cell Genomics.
Suvà ML; Tirosh I
Cancer Cell; 2020 May; 37(5):630-636. PubMed ID: 32396858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
